Bone marrow CD8 T cells are in different activation state than those in lymphoid periphery

European Journal of Immunology

Volumn 32, Issue 7, 2002, Pages 1873-1880

  Di Rosa, Francesca ^a,b,c   Santoni, Angela ^a,b  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

Author keywords

Bone marrow transplantation; Cellular activation; Immunological memory; T lymphocyte

Indexed keywords

CD8 ANTIGEN;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLAST CELL; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CANCER IMMUNOTHERAPY; CELL MATURATION; CONTROLLED STUDY; EFFECTOR CELL; HEMATOPOIESIS; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOSTIMULATION; IN VITRO STUDY; LYMPH NODE; LYMPHOID ORGAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE ACTIVATION;

ANIMALS; BONE MARROW CELLS; CD8-POSITIVE T-LYMPHOCYTES; HUMANS; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; SPLEEN; TIME FACTORS;

EID: 0036316236     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200207)32:7<1873::AID-IMMU1873>3.0.CO;2-P     Document Type: Article

References (28)

1. Histoincompatible bone marrow transplants in humans
2. New strategies for bone marrow transplantation
3. Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow
4. Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation
5. Autologous bone-marrow transplantation for rheumatoid arthritis
6. Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation
7. BMT beats autoimmune disease
8. + T cells in allogeneic bone marrow transplantation recipients
9. Bone marrow can function as a lymphoid organ during a primary immune response under conditions of disrupted lymphocyte trafficking
10. + T cells in mouse bone marrow. I. Increased activated/memory phenotype and altered TCR Vbeta repertoire
11. Bone marrow contains virus-specific cytotoxic T lymphocytes
12. + T cells to antigen stimulation in vivo
13. Simian immunodeficiency virus-specific cytotoxic T lymphocytes and cell-associated viral RNA levels in distinct lymphoid compartments of SIVmac-infected rhesus monkeys
14. Changes in cell adhesion molecule expression on T cells associated with systemic virus infection
15. Conditional vascular cell adhesion molecule 1 deletion in mice: Impaired lymphocyte migration to bone marrow
16. On the lifespan of virigin T lymphocytes
17. Shear forces promote lymphocyte migration across vascular endothelium bearing apical chemokines
18. Chemokines and chemokine receptors in T cell priming and Th1/Th2-mediated responses
19. Lifetime of plasma cells in the bone marrow
20. Humoral immunity due to long-lived plasma cells
21. Antigen-specific B cell memory: Expression and replenishment of a novel B220(-) memory B cell compartment
22. + bone marrow subpopulation that promotes allogeneic stem cell engraftment
23. Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation
24. Differential presentation of endogenously processed cytotoxic T lymphocyte epitopes by mouse hepatocarcinoma cell lines induced by SV40 large T antigen
25. + T helper and a T killer cell
26. Dendritic cells need T cell help to prime cytotoxic T cell responses to strong antigens
27. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection
28. Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor α, granulocyte-macrophage factor and γ-interferon gene or admixed with conventional adjuvants